North America Mammography Market Size, Share & Industry Analysis Report By Service (Screening, Diagnostic, and Interventional), By Imaging Modality (2D Digital, 3D Digital Breast Tomosynthesis, Contrast-enhanced, and Other Imaging Modality), By End-User (Hospitals, Specialty Clinics, Diagnostic Centers, and Other End-User), By Country and Forecast, 2026 - 2033

The North America Mammography Market is expected to reach USD 3.4 billion by 2032, growing at a CAGR of 4.7% during (2026 - 2033).

The North America Mammography Market evolved from analog film-based breast imaging into an advanced digital diagnostic ecosystem focused on earlier and more accurate breast cancer detection. The transition to digital mammography improved image quality, storage, workflow efficiency, and radiation management, while digital breast tomosynthesis introduced three-dimensional visualization that improved lesion assessment and reduced limitations associated with conventional 2D imaging. Continued technological development has expanded the market toward contrast-enhanced imaging, AI-assisted interpretation, risk assessment, and integrated digital workflows. Screening programs and increasing emphasis on personalized breast health management have further strengthened clinical adoption.

Digital breast tomosynthesis, artificial intelligence, decentralized screening, and patient-centered care are shaping current market development. AI tools increasingly support lesion detection, breast-density assessment, risk stratification, and workflow optimization, helping improve diagnostic consistency and radiologist productivity. Mobile mammography units, telemammography, and remote interpretation are expanding access across rural and underserved populations, while advanced imaging technologies provide improved visualization for complex cases. Growing focus on personalized screening protocols, patient education, reduced discomfort, interoperable imaging systems, and remote diagnostic capabilities is moving the market toward more accessible and outcome-oriented breast imaging services.

Service Outlook

Based on Service, the market is segmented into Screening, Diagnostic, and Interventional. The Screening market dominated the North America Mammography Market by Service in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 2.0 billion by 2032, growing at a CAGR of 4.3 % during the forecast period. The Diagnostic market is expected to witness a CAGR of 5.1% during (2026 - 2033). The Interventional market is expected to witness a CAGR of 5.9% during (2026 - 2033).

Screening mammography focuses on routine breast imaging for asymptomatic populations and supports preventive healthcare programs, community screening initiatives, hospital-based services, and mobile mammography outreach. Diagnostic mammography provides more detailed evaluation for symptomatic patients, abnormal screening results, palpable findings, and other suspicious abnormalities through targeted imaging and complementary assessment. Interventional mammography supports stereotactic biopsy, lesion localization, tissue sampling, and other image-guided procedures that connect imaging findings with pathology and treatment planning. Adoption across these services is increasingly influenced by digital breast tomosynthesis, AI-assisted analysis, advanced image guidance, and broader screening accessibility.

Imaging Modality Outlook

Based on Imaging Modality, the market is segmented into 2D Digital, 3D Digital Breast Tomosynthesis, Contrast-enhanced, and Other Imaging Modality. The 2D Digital market dominated the North America Mammography Market by Imaging Modality in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 1.4 billion by 2032, growing at a CAGR of 4.1 % during the forecast period. The 3D Digital Breast Tomosynthesis market is expected to witness a CAGR of 4.9% during (2026 - 2033). Additionally, The Contrast-enhanced market is expected to witness highest CAGR of 5.8% during (2026 - 2033).

2D Digital mammography remains an established imaging approach used across screening and diagnostic workflows because of its broad availability, clinical familiarity, and integration with digital image-management systems. 3D Digital Breast Tomosynthesis provides layered visualization of breast tissue and supports improved lesion detection, particularly where tissue overlap or breast density complicates interpretation. Contrast-enhanced mammography adds functional information through contrast-agent administration to improve lesion characterization and support selected diagnostic and preoperative applications. Other Imaging Modality includes complementary and emerging approaches such as automated breast ultrasound, molecular breast imaging, and other technologies addressing specific diagnostic limitations or higher-risk patient requirements.

End-User Outlook

Based on End-User, the market is segmented into Hospitals, Specialty Clinics, Diagnostic Centers, and Other End-User. Hospitals provide comprehensive mammography services within integrated screening, diagnostic, oncology, radiology, and treatment pathways and support adoption of advanced technologies such as tomosynthesis, contrast-enhanced mammography, and AI-assisted interpretation.

Specialty Clinics focus on breast health, personalized imaging, diagnostic assessment, biopsy coordination, and patient-centered services for women requiring specialized evaluation. Diagnostic Centers emphasize outpatient screening, high-volume imaging, convenience, and workflow efficiency while broadening access beyond hospital environments. Other End-User includes mobile mammography units, community health centers, federally qualified health centers, and specialized outpatient facilities focused on improving screening availability across underserved populations.

Free Valuable Insights: The Global Mammography Market will hit USD 10.0 Billion billion by 2033, at a CAGR of 5.3%

Country Outlook

Based on Country, the market is segmented into US, Canada, Mexico, and Rest of North America. The US market dominated the North America Mammography Market by Country in 2025, and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 2.7 billion by 2032, growing at a CAGR of 4.1 % during the forecast period. The Canada market is expected to witness a CAGR of 7.4% during (2026 - 2033). Additionally, The Mexico market is expected to witness a CAGR of 6.9% during (2026 - 2033).

Across North America, mammography adoption is being shaped by AI-assisted interpretation, digital breast tomosynthesis, personalized screening, remote diagnostics, and expanding access initiatives. The US emphasizes AI-supported image analysis, 3D mammography, workflow optimization, and risk-based screening, while Canada focuses on AI-assisted diagnostics, government-supported screening, personalized protocols, mobile services, and tele-radiology. Mexico is advancing AI-compatible imaging, decentralized mammography services, mobile units, quality assurance, and localized screening infrastructure, whereas Rest of North America emphasizes AI integration, tele-radiology, mobile mammography, personalized screening, contrast-enhanced imaging, and broader access across underserved communities.

List of Key Companies Profiled

• Hologic, Inc.
• GE HealthCare Technologies Inc.
• Siemens Healthineers AG
• FUJIFILM Holdings Corporation
• Planmed Oy
• IMS Giotto S.p.A.
• Metaltronica S.p.A.
• Trivitron Healthcare Pvt. Ltd.
• Allengers Medical Systems Ltd.
• MEDI-FUTURE Co., Ltd.

North America Mammography Market Report Segmentation

By Service

• Screening
• Diagnostic
• Interventional

By Imaging Modality

• 2D Digital
• 3D Digital Breast Tomosynthesis
• Contrast-enhanced
• Other Imaging Modality

By End-User

• Hospitals
• Specialty Clinics
• Diagnostic Centers
• Other End-User

By Country

• US
• Canada
• Mexico
• Rest of North America

Chapter 1. North America Market
1.1 Market Overview
1.2 Key Factors Impacting Market
1.2.1 Market Drivers
1.2.2 Market Restraints
1.2.3 Market Opportunities
1.2.4 Market Challenges
1.2.5 Market Trends
1.2.6 State of Competition
1.2.7 Market Consolidation
1.2.8 Key Customer Criteria
1.3 Product Life Cycle
1.4 Segmentation By Service
1.4.1 Screening
1.4.2 Diagnostic
1.4.3 Interventional
1.5 Segmentation By Imaging Modality
1.5.1 D Digital
1.5.2 D Digital Breast Tomosynthesis
1.5.3 Contrast-enhanced
1.5.4 Other Imaging Modality
1.6 Segmentation By End-User
1.6.1 Hospitals
1.6.2 Specialty Clinics
1.6.3 Diagnostic Centers
1.6.4 Other End-User
1.7 Segmentation By Country
1.7.1 US
1.7.1.1 Segmentation By Service
1.7.1.1.1 Screening
1.7.1.1.2 Diagnostic
1.7.1.1.3 Interventional
1.7.1.2 Segmentation By Imaging Modality
1.7.1.2.1 D Digital
1.7.1.2.2 D Digital Breast Tomosynthesis
1.7.1.2.3 Contrast-Enhanced
1.7.1.2.4 Other Imaging Modality
1.7.1.3 Segmentation By End-User
1.7.1.3.1 Hospitals
1.7.1.3.2 Specialty Clinics
1.7.1.3.3 Diagnostic Centers
1.7.1.3.4 Other End-User
1.7.2 Canada
1.7.2.1 Segmentation By Service
1.7.2.1.1 Screening
1.7.2.1.2 Diagnostic
1.7.2.1.3 Interventional
1.7.2.2 Segmentation By Imaging Modality
1.7.2.2.1 D Digital
1.7.2.2.2 D Digital Breast Tomosynthesis
1.7.2.2.3 Contrast-Enhanced
1.7.2.2.4 Other Imaging Modality
1.7.2.3 Segmentation By End-User
1.7.2.3.1 Hospitals
1.7.2.3.2 Specialty Clinics
1.7.2.3.3 Diagnostic Centers
1.7.2.3.4 Other End-User
1.7.3 Mexico
1.7.3.1 Segmentation By Service
1.7.3.1.1 Screening
1.7.3.1.2 Diagnostic
1.7.3.1.3 Interventional
1.7.3.2 Segmentation By Imaging Modality
1.7.3.2.1 D Digital
1.7.3.2.2 D Digital Breast Tomosynthesis
1.7.3.2.3 Contrast-Enhanced
1.7.3.2.4 Other Imaging Modality
1.7.3.3 Segmentation By End-User
1.7.3.3.1 Hospitals
1.7.3.3.2 Specialty Clinics
1.7.3.3.3 Diagnostic Centers
1.7.3.3.4 Other End-User
1.7.4 Rest of North America
1.7.4.1 Segmentation By Service
1.7.4.1.1 Screening
1.7.4.1.2 Diagnostic
1.7.4.1.3 Interventional
1.7.4.2 Segmentation By Imaging Modality
1.7.4.2.1 D Digital
1.7.4.2.2 D Digital Breast Tomosynthesis
1.7.4.2.3 Contrast-Enhanced
1.7.4.2.4 Other Imaging Modality
1.7.4.3 Segmentation By End-User
1.7.4.3.1 Hospitals
1.7.4.3.2 Specialty Clinics
1.7.4.3.3 Diagnostic Centers
1.7.4.3.4 Other End-User


Chapter 2. Company Snapshots
2.1 Hologic, Inc.
2.1.1 Business Overview
2.1.2 Key Information
2.1.3 Company Focus on Mammography Market
2.1.4 Strategic Insights
2.1.5 Strategy Deployed
2.1.6 Product & Service Portfolio
2.1.7 Capability Overview
2.1.8 Core Competencies
2.1.9 Technology & Innovation Focus
2.1.10 SWOT Analysis
2.1.11 Customers / End Users
2.1.12 Competitive Positioning
2.1.13 Key Differentiators
2.1.14 Mammography Portfolio Matrix
2.1.15 Analyst View
2.1.16 Future Outlook
2.2 GE HealthCare Technologies Inc.
2.2.1 Business Overview
2.2.2 Key Information
2.2.3 Company Focus on Mammography Market
2.2.4 Strategic Insights
2.2.5 Strategy Deployed
2.2.6 Product & Service Portfolio
2.2.7 Capability Overview
2.2.8 Technology & Innovation Focus
2.2.9 SWOT Analysis
2.2.10 Customers / End Users
2.2.11 Competitive Positioning
2.2.12 Key Differentiators
2.2.13 Mammography Portfolio Matrix
2.2.14 Analyst View
2.2.15 Future Outlook
2.3 Siemens Healthineers AG
2.3.1 Business Overview
2.3.2 Key Information
2.3.3 Company Focus on Mammography Market
2.3.4 Strategic Insights
2.3.5 Strategy Deployed
2.3.6 Product & Service Portfolio
2.3.7 Capability Overview
2.3.8 Core Competencies
2.3.9 Technology & Innovation Focus
2.3.10 SWOT Analysis
2.3.11 Customers / End Users
2.3.12 Competitive Positioning
2.3.13 Key Differentiators
2.3.14 Mammography Portfolio Matrix
2.3.15 Analyst View
2.3.16 Future Outlook
2.4 FUJIFILM Holdings Corporation
2.4.1 Business Overview
2.4.2 Key Information
2.4.3 Company Focus on Mammography Market
2.4.4 Strategic Insights
2.4.5 Strategy Deployed
2.4.6 Product & Service Portfolio
2.4.7 Capability Overview
2.4.8 Core Competencies
2.4.9 Technology & Innovation Focus
2.4.10 SWOT Analysis
2.4.11 Customers / End Users
2.4.12 Competitive Positioning
2.4.13 Key Differentiators
2.4.14 Mammography Portfolio Matrix
2.4.15 Analyst View
2.4.16 Future Outlook
2.5 Planmed Oy
2.5.1 Business Overview
2.5.2 Key Information
2.5.3 Company Focus on Mammography Market
2.5.4 Strategic Insights
2.5.5 Strategy Deployed
2.5.6 Product & Service Portfolio
2.5.7 Capability Overview
2.5.8 Core Competencies
2.5.9 Technology & Innovation Focus
2.5.10 SWOT Analysis
2.5.11 Customers / End Users
2.5.12 Competitive Positioning
2.5.13 Key Differentiators
2.5.14 Mammography Portfolio Matrix
2.5.15 Analyst View
2.5.16 Future Outlook
2.6 IMS Giotto S.p.A.
2.6.1 Business Overview
2.6.2 Key Information
2.6.3 Company Focus on Mammography Market
2.6.4 Strategic Insights
2.6.5 Strategy Deployed
2.6.6 Product & Service Portfolio
2.6.7 Capability Overview
2.6.8 Technology & Innovation Focus
2.6.9 SWOT Analysis
2.6.10 Customers / End Users
2.6.11 Competitive Positioning
2.6.12 Key Differentiators
2.6.13 Portfolio Matrix
2.6.14 Analyst View
2.6.15 Future Outlook
2.7 Metaltronica S.p.A.
2.7.1 Business Overview
2.7.2 Key Information
2.7.3 Company Focus on Mammography Market
2.7.4 Strategic Insights on Mammography Market
2.7.5 Strategy Deployed
2.7.6 Product & Service Portfolio
2.7.7 Capability Overview
2.7.8 Technology & Innovation Focus
2.7.9 SWOT Analysis
2.7.10 Customers / End Users
2.7.11 Competitive Positioning
2.7.12 Key Differentiators
2.7.13 Portfolio Matrix
2.7.14 Analyst View
2.7.15 Future Outlook
2.8 Trivitron Healthcare Pvt. Ltd.
2.8.1 Business Overview
2.8.2 Key Information
2.8.3 Company Focus on Mammography Market
2.8.4 Strategic Insights
2.8.5 Strategy Deployed
2.8.6 Product & Service Portfolio
2.8.7 Capability Overview
2.8.8 Technology & Innovation Focus
2.8.9 SWOT Analysis
2.8.10 Customers / End Users
2.8.11 Competitive Positioning
2.8.12 Key Differentiators
2.8.13 Portfolio Matrix
2.8.14 Analyst View
2.8.15 Future Outlook
2.9 Allengers Medical Systems Ltd.
2.9.1 Business Overview
2.9.2 Key Information
2.9.3 Company Focus on Mammography Market
2.9.4 Strategic Insights
2.9.5 Strategy Deployed
2.9.6 Product & Service Portfolio
2.9.7 Capability Overview
2.9.8 Technology & Innovation Focus
2.9.9 SWOT Analysis
2.9.10 Customers / End Users
2.9.11 Competitive Positioning
2.9.12 Key Differentiators
2.9.13 Portfolio Matrix
2.9.14 Analyst View
2.9.15 Future Outlook
2.10 MEDI-FUTURE Co., Ltd.
2.10.1 Business Overview
2.10.2 Key Information
2.10.3 Company Focus on Mammography Market
2.10.4 Strategic Insights
2.10.5 Strategy Deployed
2.10.6 Product & Service Portfolio
2.10.7 Capability Overview 2.10.8 Technology & Innovation Focus
2.10.9 SWOT Analysis
2.10.10 Customers / End Users
2.10.11 Competitive Positioning
2.10.12 Key Differentiators
2.10.13 Portfolio Matrix
2.10.14 Analyst View
2.10.15 Future Outlook

List of Tables
Table 1 North America Mammography Market Market, 2022 - 2033, USD Million
Table 2 North America Mammography Market Market by End-User, 2022 - 2033, USD Million
Table 3 North America Diagnostic Centers Market, 2022 - 2033, USD Million
Table 4 North America Hospitals Market, 2022 - 2033, USD Million
Table 5 North America Other End-User Market, 2022 - 2033, USD Million
Table 6 North America Specialty Clinics Market, 2022 - 2033, USD Million
Table 7 North America Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
Table 8 North America 2D Digital Market, 2022 - 2033, USD Million
Table 9 North America 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
Table 10 North America Contrast-enhanced Market, 2022 - 2033, USD Million
Table 11 North America Other Imaging Modality Market, 2022 - 2033, USD Million
Table 12 North America Mammography Market Market by Service, 2022 - 2033, USD Million
Table 13 North America Diagnostic Market, 2022 - 2033, USD Million
Table 14 North America Interventional Market, 2022 - 2033, USD Million
Table 15 North America Screening Market, 2022 - 2033, USD Million
Table 16 United States Mammography Market Market, 2022 - 2033, USD Million
Table 17 United States Mammography Market Market by End-User, 2022 - 2033, USD Million
Table 18 United States Diagnostic Centers Market, 2022 - 2033, USD Million
Table 19 United States Hospitals Market, 2022 - 2033, USD Million
Table 20 United States Other End-User Market, 2022 - 2033, USD Million
Table 21 United States Specialty Clinics Market, 2022 - 2033, USD Million
Table 22 United States Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
Table 23 United States 2D Digital Market, 2022 - 2033, USD Million
Table 24 United States 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
Table 25 United States Contrast-enhanced Market, 2022 - 2033, USD Million
Table 26 United States Other Imaging Modality Market, 2022 - 2033, USD Million
Table 27 United States Mammography Market Market by Service, 2022 - 2033, USD Million
Table 28 United States Diagnostic Market, 2022 - 2033, USD Million
Table 29 United States Interventional Market, 2022 - 2033, USD Million
Table 30 United States Screening Market, 2022 - 2033, USD Million
Table 31 Canada Mammography Market Market, 2022 - 2033, USD Million
Table 32 Canada Mammography Market Market by End-User, 2022 - 2033, USD Million
Table 33 Canada Diagnostic Centers Market, 2022 - 2033, USD Million
Table 34 Canada Hospitals Market, 2022 - 2033, USD Million
Table 35 Canada Other End-User Market, 2022 - 2033, USD Million
Table 36 Canada Specialty Clinics Market, 2022 - 2033, USD Million
Table 37 Canada Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
Table 38 Canada 2D Digital Market, 2022 - 2033, USD Million
Table 39 Canada 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
Table 40 Canada Contrast-enhanced Market, 2022 - 2033, USD Million
Table 41 Canada Other Imaging Modality Market, 2022 - 2033, USD Million
Table 42 Canada Mammography Market Market by Service, 2022 - 2033, USD Million
Table 43 Canada Diagnostic Market, 2022 - 2033, USD Million
Table 44 Canada Interventional Market, 2022 - 2033, USD Million
Table 45 Canada Screening Market, 2022 - 2033, USD Million
Table 46 Mexico Mammography Market Market, 2022 - 2033, USD Million
Table 47 Mexico Mammography Market Market by End-User, 2022 - 2033, USD Million
Table 48 Mexico Diagnostic Centers Market, 2022 - 2033, USD Million
Table 49 Mexico Hospitals Market, 2022 - 2033, USD Million
Table 50 Mexico Other End-User Market, 2022 - 2033, USD Million
Table 51 Mexico Specialty Clinics Market, 2022 - 2033, USD Million
Table 52 Mexico Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
Table 53 Mexico 2D Digital Market, 2022 - 2033, USD Million
Table 54 Mexico 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
Table 55 Mexico Contrast-enhanced Market, 2022 - 2033, USD Million
Table 56 Mexico Other Imaging Modality Market, 2022 - 2033, USD Million
Table 57 Mexico Mammography Market Market by Service, 2022 - 2033, USD Million
Table 58 Mexico Diagnostic Market, 2022 - 2033, USD Million
Table 59 Mexico Interventional Market, 2022 - 2033, USD Million
Table 60 Mexico Screening Market, 2022 - 2033, USD Million
Table 61 Rest of North America Mammography Market Market, 2022 - 2033, USD Million
Table 62 Rest of North America Mammography Market Market by End-User, 2022 - 2033, USD Million
Table 63 Rest of North America Diagnostic Centers Market, 2022 - 2033, USD Million
Table 64 Rest of North America Hospitals Market, 2022 - 2033, USD Million
Table 65 Rest of North America Other End-User Market, 2022 - 2033, USD Million
Table 66 Rest of North America Specialty Clinics Market, 2022 - 2033, USD Million
Table 67 Rest of North America Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
Table 68 Rest of North America 2D Digital Market, 2022 - 2033, USD Million
Table 69 Rest of North America 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
Table 70 Rest of North America Contrast-enhanced Market, 2022 - 2033, USD Million
Table 71 Rest of North America Other Imaging Modality Market, 2022 - 2033, USD Million
Table 72 Rest of North America Mammography Market Market by Service, 2022 - 2033, USD Million
Table 73 Rest of North America Diagnostic Market, 2022 - 2033, USD Million
Table 74 Rest of North America Interventional Market, 2022 - 2033, USD Million
Table 75 Rest of North America Screening Market, 2022 - 2033, USD Million


List of Figures
FIG 1 Key Factors Impacting Market
FIG 2 Market Consolidation
FIG 3 Key Customer Criteria
FIG 4 Product Life Cycle
FIG 5 North America Mammography Market Market, 2022 - 2033, USD Million
FIG 6 North America Mammography Market Market by End-User, 2022 - 2033, USD Million
FIG 7 North America Diagnostic Centers Market, 2022 - 2033, USD Million
FIG 8 North America Hospitals Market, 2022 - 2033, USD Million
FIG 9 North America Other End-User Market, 2022 - 2033, USD Million
FIG 10 North America Specialty Clinics Market, 2022 - 2033, USD Million
FIG 11 North America Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
FIG 12 North America 2D Digital Market, 2022 - 2033, USD Million
FIG 13 North America 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
FIG 14 North America Contrast-enhanced Market, 2022 - 2033, USD Million
FIG 15 North America Other Imaging Modality Market, 2022 - 2033, USD Million
FIG 16 North America Mammography Market Market by Service, 2022 - 2033, USD Million
FIG 17 North America Diagnostic Market, 2022 - 2033, USD Million
FIG 18 North America Interventional Market, 2022 - 2033, USD Million
FIG 19 North America Screening Market, 2022 - 2033, USD Million
FIG 20 United States Mammography Market Market, 2022 - 2033, USD Million
FIG 21 United States Mammography Market Market by End-User, 2022 - 2033, USD Million
FIG 22 United States Diagnostic Centers Market, 2022 - 2033, USD Million
FIG 23 United States Hospitals Market, 2022 - 2033, USD Million
FIG 24 United States Other End-User Market, 2022 - 2033, USD Million
FIG 25 United States Specialty Clinics Market, 2022 - 2033, USD Million
FIG 26 United States Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
FIG 27 United States 2D Digital Market, 2022 - 2033, USD Million
FIG 28 United States 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
FIG 29 United States Contrast-enhanced Market, 2022 - 2033, USD Million
FIG 30 United States Other Imaging Modality Market, 2022 - 2033, USD Million
FIG 31 United States Mammography Market Market by Service, 2022 - 2033, USD Million
FIG 32 United States Diagnostic Market, 2022 - 2033, USD Million
FIG 33 United States Interventional Market, 2022 - 2033, USD Million
FIG 34 United States Screening Market, 2022 - 2033, USD Million
FIG 35 Canada Mammography Market Market, 2022 - 2033, USD Million
FIG 36 Canada Mammography Market Market by End-User, 2022 - 2033, USD Million
FIG 37 Canada Diagnostic Centers Market, 2022 - 2033, USD Million
FIG 38 Canada Hospitals Market, 2022 - 2033, USD Million
FIG 39 Canada Other End-User Market, 2022 - 2033, USD Million
FIG 40 Canada Specialty Clinics Market, 2022 - 2033, USD Million
FIG 41 Canada Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
FIG 42 Canada 2D Digital Market, 2022 - 2033, USD Million
FIG 43 Canada 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
FIG 44 Canada Contrast-enhanced Market, 2022 - 2033, USD Million
FIG 45 Canada Other Imaging Modality Market, 2022 - 2033, USD Million
FIG 46 Canada Mammography Market Market by Service, 2022 - 2033, USD Million
FIG 47 Canada Diagnostic Market, 2022 - 2033, USD Million
FIG 48 Canada Interventional Market, 2022 - 2033, USD Million
FIG 49 Canada Screening Market, 2022 - 2033, USD Million
FIG 50 Mexico Mammography Market Market, 2022 - 2033, USD Million
FIG 51 Mexico Mammography Market Market by End-User, 2022 - 2033, USD Million
FIG 52 Mexico Diagnostic Centers Market, 2022 - 2033, USD Million
FIG 53 Mexico Hospitals Market, 2022 - 2033, USD Million
FIG 54 Mexico Other End-User Market, 2022 - 2033, USD Million
FIG 55 Mexico Specialty Clinics Market, 2022 - 2033, USD Million
FIG 56 Mexico Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
FIG 57 Mexico 2D Digital Market, 2022 - 2033, USD Million
FIG 58 Mexico 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
FIG 59 Mexico Contrast-enhanced Market, 2022 - 2033, USD Million
FIG 60 Mexico Other Imaging Modality Market, 2022 - 2033, USD Million
FIG 61 Mexico Mammography Market Market by Service, 2022 - 2033, USD Million
FIG 62 Mexico Diagnostic Market, 2022 - 2033, USD Million
FIG 63 Mexico Interventional Market, 2022 - 2033, USD Million
FIG 64 Mexico Screening Market, 2022 - 2033, USD Million
FIG 65 Rest of North America Mammography Market Market, 2022 - 2033, USD Million
FIG 66 Rest of North America Mammography Market Market by End-User, 2022 - 2033, USD Million
FIG 67 Rest of North America Diagnostic Centers Market, 2022 - 2033, USD Million
FIG 68 Rest of North America Hospitals Market, 2022 - 2033, USD Million
FIG 69 Rest of North America Other End-User Market, 2022 - 2033, USD Million
FIG 70 Rest of North America Specialty Clinics Market, 2022 - 2033, USD Million
FIG 71 Rest of North America Mammography Market Market by Imaging Modality, 2022 - 2033, USD Million
FIG 72 Rest of North America 2D Digital Market, 2022 - 2033, USD Million
FIG 73 Rest of North America 3D Digital Breast Tomosynthesis Market, 2022 - 2033, USD Million
FIG 74 Rest of North America Contrast-enhanced Market, 2022 - 2033, USD Million
FIG 75 Rest of North America Other Imaging Modality Market, 2022 - 2033, USD Million
FIG 76 Rest of North America Mammography Market Market by Service, 2022 - 2033, USD Million
FIG 77 Rest of North America Diagnostic Market, 2022 - 2033, USD Million
FIG 78 Rest of North America Interventional Market, 2022 - 2033, USD Million
FIG 79 Rest of North America Screening Market, 2022 - 2033, USD Million